AMERIPRISE FINANCIAL INC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 67 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$95,000
+82.7%
163,400
-0.9%
0.00%
Q3 2022$52,000
+1200.0%
164,835
+1372.0%
0.00%
Q2 2022$4,000
-83.3%
11,198
+6.2%
0.00%
Q4 2021$24,000
-45.5%
10,549
-31.0%
0.00%
Q3 2021$44,000
-78.8%
15,297
-72.1%
0.00%
Q2 2021$208,000
+201.4%
54,877
+167.7%
0.00%
Q1 2021$69,000
+40.8%
20,497
+17.3%
0.00%
Q4 2020$49,000
+14.0%
17,479
+2.5%
0.00%
Q3 2020$43,000
-97.6%
17,058
-87.2%
0.00%
-100.0%
Q2 2020$1,817,000
+515.9%
133,765
+243.6%
0.00%
Q1 2020$295,000
+23.9%
38,936
+3.3%
0.00%
Q4 2019$238,000
+78.9%
37,676
+8.3%
0.00%
Q3 2019$133,000
-5.0%
34,801
+20.2%
0.00%
Q2 2019$140,000
-73.4%
28,956
-55.0%
0.00%
Q1 2019$527,000
-54.2%
64,356
-69.1%
0.00%
-100.0%
Q4 2018$1,151,000
+258.6%
208,090
+472.9%
0.00%
Q3 2018$321,000
+63.8%
36,324
+85.5%
0.00%
Q2 2018$196,000
-76.2%
19,584
-77.4%
0.00%
Q1 2018$825,000
-67.0%
86,579
-48.5%
0.00%
-100.0%
Q4 2017$2,501,000
-18.7%
168,206
+7.5%
0.00%0.0%
Q3 2017$3,078,000
+152.7%
156,500
+84.9%
0.00%0.0%
Q2 2017$1,218,000
-49.4%
84,655
-54.6%
0.00%0.0%
Q4 2015$2,409,000
+43.9%
186,524
+7.6%
0.00%0.0%
Q3 2015$1,674,000173,3340.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$13,027,0005.13%
Orchard Capital Management, LLC 857,138$2,400,0001.02%
Nantahala Capital Management 7,040,487$19,713,0000.61%
OCCUDO QUANTITATIVE STRATEGIES LP 209,040$585,0000.18%
Woodline Partners LP 2,382,522$6,671,0000.18%
RICE HALL JAMES & ASSOCIATES, LLC 1,546,169$4,329,0000.15%
Virtus ETF Advisers LLC 92,771$260,0000.11%
Jump Financial, LLC 155,583$435,0000.07%
GSA CAPITAL PARTNERS LLP 128,626$360,0000.06%
Anson Funds Management LP 95,342$267,0000.05%
View complete list of AKEBIA THERAPEUTICS INC shareholders